Occurrence of COVID-19 in cystic fibrosis patients: a review

FS Abolhasani, M Moein, N Rezaie… - Frontiers in …, 2024 - frontiersin.org
Cystic fibrosis (CF) is a genetic ailment caused by mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene. This autosomal recessive disorder is …

[HTML][HTML] SARS-CoV-2 infection in patients with cystic fibrosis. An overwiew

V Fainardi, F Longo, A Chetta… - Acta Bio Medica: Atenei …, 2020 - ncbi.nlm.nih.gov
The novel coronavirus SARS-CoV-2 was first identified in China in December 2019 and has
since spread worldwide. People with Cystic Fibrosis (CF) have reduced survival mainly …

SARS-CoV-2 infection in patients with cystic fibrosis: what we know so far

C Biondo, A Midiri, E Gerace, S Zummo, G Mancuso - Life, 2022 - mdpi.com
Respiratory infections are the most common and most frequent diseases, especially in
children and the elderly, characterized by a clear seasonality and with an incidence that …

The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review

A Vitiello, M Sabbatucci, A Silenzi, A Capuano… - Respiratory …, 2023 - Springer
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …

Incidence, prevalence, clinical features, and outcomes of COVID-19 in persons with cystic fibrosis: a systematic review protocol

S Antony, SS Vargese, MJ Idikula… - JBI evidence …, 2022 - journals.lww.com
Objective: The objective of this review is to determine the incidence and prevalence, clinical
features, and outcomes of COVID-19 in persons with cystic fibrosis. Introduction: Cystic …

Epidemiological profile of hospitalized patients with cystic fibrosis in Brazil due to severe acute respiratory infection during the COVID-19 pandemic and a systematic …

LS Marques, MN Boschiero, NMS Sansone… - Healthcare, 2023 - mdpi.com
Since the onset of the coronavirus disease, COVID-19 pandemic, concern arose for those
who might be at higher risk of a worse COVID-19 prognosis, such as those with cystic …

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020

C Colombo, G Alicandro, V Daccó, V Gagliano… - PLoS …, 2021 - journals.plos.org
Objective To describe the symptoms and clinical course of SARS-CoV-2 infection in patients
with cystic fibrosis (CF). Methods We carried out a prospective multicentre cohort study …

[HTML][HTML] Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey

P Mondejar-Lopez, E Quintana-Gallego… - Respiratory …, 2020 - Elsevier
Background Given the high incidence of confirmed infection by SARS-CoV-2 and mortality
by COVID-19 in the Spanish population, its impact was analysed among persons with Cystic …

Cystic fibrosis: fighting together against coronavirus infection

S Manti, GF Parisi, M Papale, E Mulè, D Aloisio… - Frontiers in …, 2020 - frontiersin.org
In a critical moment like this in which all world population is hard fighting with limited
weapons against coronavirus (COVID-19) infection, we strongly feel the duty and the need …

COVID-19 meets Cystic Fibrosis: for better or worse?

D Peckham, MF McDermott, S Savic, A Mehta - Genes & Immunity, 2020 - nature.com
Cystic fibrosis (CF) is one of the most common autosomal recessive life-limiting conditions
affecting Caucasians. The resulting defect in the cystic fibrosis transmembrane conductance …